Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice

Abstract

MSC treatment significantly reduces H9N2 AIV-induced acute lung injury in mice and is associated with reduced pulmonary inflammation. These results indicate a potential role for MSC therapy in the treatment of clinical avian influenza.